orforglipron


anonymous

Guest
8 percent weight loss at 40 wks, 26 percent patients experienced diarrhea, 16 percent experienced nausea, these are terrible results. Once the market wakes from the hype, lly is going down. BTW. 36 mgs is a horse pill.
 


8 percent weight loss at 40 wks, 26 percent patients experienced diarrhea, 16 percent experienced nausea, these are terrible results. Once the market wakes from the hype, lly is going down. BTW. 36 mgs is a horse pill.
The A1C drop is pretty damn good. It's a pill, it's going to be cheaper, easier to take, with a nice benefit of some weight drop. it's not Mounjaro, but not a bad option for patients with diabetes who don't need to loose much weight
 


The A1C drop is pretty damn good. It's a pill, it's going to be cheaper, easier to take, with a nice benefit of some weight drop. it's not Mounjaro, but not a bad option for patients with diabetes who don't need to loose much weight
Wake up, "A significant majority of diabetes patients are either overweight or obese. Studies consistently show that over 80% of individuals with type 2 diabetes are overweight or obese."
 


Wake up, "A significant majority of diabetes patients are either overweight or obese. Studies consistently show that over 80% of individuals with type 2 diabetes are overweight or obese."
80% of US population, in the southeastern US, particularly, yes. But Asian and Indian populations are usually not that overweight yet have diabetes. In the western US we have a lot of those patients so there will be a market for the pill there. The rest of the world is not as overweight/obese as some of the US population so plenty of opportunity there
 




80% of US population, in the southeastern US, particularly, yes. But Asian and Indian populations are usually not that overweight yet have diabetes. In the western US we have a lot of those patients so there will be a market for the pill there. The rest of the world is not as overweight/obese as some of the US population so plenty of opportunity there
Any idea what cars that sales group will be choosing
 


Honesty here, we need something to talk about at the ADA that's positive after the SURPASS-CVOT results are negative.
Do you really think it will be that bad? It sounds like it raises possibility of GIP having a worsening effect on CV outcomes, but something that would need further investigation to create a direct link. Plus, how much of a difference is it anyways?
 





Write your reply...